• Depot
  • Watchlist
  • Glocke
  • Handeln

    • Novozymes AS B News

    52,35 € 0,00% +0,00 €
    11:24:31 Uhr L&S RT aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1JP9Y
    ISIN: DK0060336014
    US-Symbol: NVZMF
    Typ: Aktie

    Novozymes AS B News

    01.02.24 - GlobeNewswire
    Legacy Novozymes delivers solid last full-year results
    Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth ...
    29.01.24 - GlobeNewswire
    The combination of Novozymes and Chr. Hansen is now successfully completed, creating Novonesis – a leading global biosolutions partner
    Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-...
    09.12.23 - The Motley Fool
    Talsohle durchschritten: Diese 2 Aktien können derzeit mit einem fantastischen Aufholpotenzial glänzen!
    Wieder neigt sich ein ereignisreiches Börsenjahr dem Ende zu. Und so wie es aussieht, werden es die großen Indizes aus Deutschland und den USA mit einem deutlichen Plus ...
    09.11.23 - GlobeNewswire
    Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment
    Novozymes, a global leader in biosolutions, marks a significant milestone in the renewable diesel and SAF (Sustainable Aviation Fuel) industry with the launch of Quara® LowP, an ...
    26.10.23 - PR Newswire
    Not Just Yogurt Anymore
    Not Just Yogurt Anymore PR Newswire
    26.10.23 - GlobeNewswire
    Novozymes accelerates growth in Q3 and is on track to deliver on full-year expectations
    After the first nine months of the 2023 financial year, Novozymes sees increasing demand for sustainable biosolutions and delivers 5 % organic sales growth. The full-year organic ...
    03.10.23 - PR Newswire
    Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row
    Novozymes Named EPA Safer Choice Partner of the Year for Third Year in a Row PR Newswire
    09.08.23 - GlobeNewswire
    Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook
    After the first half of 2023, Novozymes sees overall stability in a volatile environment and delivers 3 % organic sales growth. Following destocking and lower consumer demand, the ...
    26.04.23 - GlobeNewswire
    Novozymes delivers stronger than expected Q1 results
    After the first quarter of 2023, Novozymes delivers stronger results than expected with 5% organic sales growth. The company confirms the 2023 outlook of 4-7% which is expected ...
    30.03.23 - GlobeNewswire
    Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
    The proposed combination of Novozymes and Chr. Hansen has now been approved by each company’s respective shareholders, and with strong support from the shareholders the ...
    26.01.23 - GlobeNewswire
    Novozymes delivers historically strong full-year results
    Novozymes is delivering strong growth and earnings in a volatile market environment with 9% organic sales growth in 2022. This marks the highest organic sales growth in more ...
    16.12.22 - Platow
    Novozymes macht Quantensprung
    In Skandinavien entsteht gerade eine fast märchenhafte Verbindung. Getrieben vom gemeinsamen Anteilseigner Novo Holding schließen sich die beiden hochprofitablen, in sich ...
    12.12.22 - dpa-AFX
    AKTIEN IM FOKUS: Fusion von Novozymes mit Chr. Hansen treibt Symrise an
    Eine Fusion der Enzymspezialisten Novozymes und Chr. Hansen hat am Montag Fantasie in die Branche der Hersteller von Lebensmittelzusätzen gebracht. Insbesondere der Dax-...
    12.12.22 - GlobeNewswire
    Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner
    Today, Novozymes and Chr. Hansen have entered into an agreement to create a leading global biosolutions partner through a statutory merger of the two companies. The ...
    10.11.22 - GlobeNewswire
    As one of the first companies in the world, Novozymes has had its net-zero target validated by the Science Based Targets initiative
    Novozymes has renewed its climate targets and by 2030 will reduce its absolute CO2 emissions across its operation by 75% and reduce its absolute CO2 emissions from its ...
    03.11.22 - GlobeNewswire
    Novozymes confirms upgraded guidance by strong start to Q4
    Novozymes delivered 9% organic sales growth in the first nine months of 2022 and 6% organic sales growth in the third quarter. As announced on October 7, the full-year organic ...
    11.08.22 - PLX
    Novozymes Q2 Earnings Top Expectations with Strong Organic Growth; Guidance Raised
    (PLX AI) – Novozymes Q2 sales DKK 4,286 million vs. estimate DKK 4,064 million. • Q2 net income DKK 817 million • Q2 EBIT DKK 1,110 million vs. estimate DKK 1,059 million • Q2 ...
    15.07.22 - GlobeNewswire
    Novozymes plan to further increase prices across the portfolio in response to the significant and persistent hike in incoming cost
    Novozymes has experienced unprecedented cost-​inflation on raw materials, energy, and logistics. T o recover these headwinds, substantial price increases will be implemented.
    07.06.22 - GlobeNewswire
    Novozymes extends the lifetime of textiles with sustainable innovation
    Consumer and regulatory demands for more sustainable clothing and textiles are growing and the fashion industry is rising to the challenge. Now Novozymes offers biopolishing for ...
    30.05.22 - Newsfile
    Industry Leader Novozymes OneHealth's White Paper on Helicobacter Pylori Research was Officially Released
    Shanghai, China--(Newsfile Corp. - May 30, 2022) - On May 28, the White Paper on Helicobacter Pylori research by OneHealth, an industry leader, was officially released. In recent ...

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »